Cargando…

Immune Checkpoint and Anti-Angiogenic Antibodies for the Treatment of Non-Small Cell Lung Cancer in the European Union and United States

Several types of antibodies (Abs) are currently used in non-small cell lung cancer (NSCLC). Anti-angiogenic and immune checkpoint inhibitor (ICI) Abs are the most frequent treatments used alone or with chemotherapy in metastatic NSCLC, for the front line and beyond. Considering the many therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferreira, Marion, Secher, Thomas, Heuze-Vourc’H, Nathalie, Reckamp, Karen L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234109/ https://www.ncbi.nlm.nih.gov/pubmed/34205484 http://dx.doi.org/10.3390/pharmaceutics13060912

Ejemplares similares

Immunotherapy improves the prognosis of lung cancer: do we have to change intensive care unit admission and triage guidelines?
por: Guillon, Antoine, et al.
Publicado: (2017)

Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
por: Pitiot, Aubin, et al.
Publicado: (2022)

Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!
por: Sécher, Thomas, et al.
Publicado: (2019)

Therapeutic Antibodies for the Treatment of Respiratory Tract Infections—Current Overview and Perspectives
por: Mayor, Alexie, et al.
Publicado: (2021)

Aggregates Associated with Instability of Antibodies during Aerosolization Induce Adverse Immunological Effects
por: Sécher, Thomas, et al.
Publicado: (2022)

Inhaled antibodies: formulations require specific development to overcome instability due to nebulization
por: Mayor, Alexie, et al.
Publicado: (2021)

Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model
por: Chesnay, Adélaïde, et al.
Publicado: (2022)

Therapeutic antibodies – natural and pathological barriers and strategies to overcome them
por: Al Ojaimi, Yara, et al.
Publicado: (2022)

Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 – April 1, 2016, Tours, France
por: Desoubeaux, Guillaume, et al.
Publicado: (2016)

Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer()
por: Lavergne, Marion, et al.
Publicado: (2013)

High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis
por: Nathalie, Heuzé-Vourc’h, et al.
Publicado: (2009)

Low-Frequency Intrapulmonary Percussive Ventilation Increases Aerosol Penetration in a 2-Compartment Physical Model of Fibrotic Lung Disease
por: Le Guellec, Sandrine, et al.
Publicado: (2020)

Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
por: Ciciola, Paola, et al.
Publicado: (2020)

Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies
por: Chan, Anissa S. H., et al.
Publicado: (2022)

Targeting Aspergillus fumigatus Crf Transglycosylases With Neutralizing Antibody Is Relevant but Not Sufficient to Erase Fungal Burden in a Neutropenic Rat Model
por: Chauvin, David, et al.
Publicado: (2019)

Correction: Inhibition of Wnt/β-Catenin Signaling by a Soluble Collagen-Derived Frizzled Domain Interacting with Wnt3a and the Receptors Frizzled 1 and 8
por: Hendaoui, Ismaïl, et al.
Publicado: (2012)

Inhibition of Wnt/β-Catenin Signaling by a Soluble Collagen-Derived Frizzled Domain Interacting with Wnt3a and the Receptors Frizzled 1 and 8
por: Hendaoui, Ismaïl, et al.
Publicado: (2012)

Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors
por: Brellier, Florence, et al.
Publicado: (2012)

Insights into the primate trade into the European Union and the United Kingdom
por: Svensson, Magdalena S., et al.
Publicado: (2023)

Editorial: Impact of immunotherapy in lung cancer
por: Ferreira, Marion, et al.
Publicado: (2022)

Human kallikrein-related peptidase 12 stimulates endothelial cell migration by remodeling the fibronectin matrix
por: Kryza, T., et al.
Publicado: (2018)

TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions
por: Gaud, Guillaume, et al.
Publicado: (2011)

The European Health Union and the protection of public health in the European Union: Is the European Union prepared for future cross-border health threats?
por: Seitz, Claudia
Publicado: (2023)

Combination of Immune Checkpoint Inhibitors and Anti-Angiogenic Agents in Brain Metastases From Non-Small Cell Lung Cancer
por: Fang, Likui, et al.
Publicado: (2021)

The European Union and the Regions /
Publicado: (1995)

Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis
por: Dalloneau, Emilie, et al.
Publicado: (2016)

Tetrafunctional Block Copolymers Promote Lung Gene Transfer in Newborn Piglets
por: Caballero, Ignacio, et al.
Publicado: (2019)

The legal frameworks that govern fetal surgery in the United Kingdom, European Union, and the United States
por: Cao, Kevin X., et al.
Publicado: (2018)

A survey on the state of nanosafety research in the European Union and the United States
por: Duschl, Albert, et al.
Publicado: (2018)

Effects of combining immune checkpoint inhibitors and anti-angiogenic agents on bone metastasis in non-small cell lung cancer patients
por: Xie, Xiaohong, et al.
Publicado: (2023)

Lack of FcRn Impairs Natural Killer Cell Development and Functions in the Tumor Microenvironment
por: Castaneda, Diana Cadena, et al.
Publicado: (2018)

Report on the state of the European Union /
Publicado: (2005)

The government and politics of the European Union /
por: Nugent, Neill
Publicado: (1994)

Bluetongue Epidemiology in the European Union
por: Saegerman, Claude, et al.
Publicado: (2008)

Policy-making in the European Union
por: Wallace, Helen, et al.
Publicado: (2015)

European Union Retreat at CERN
por: Ordan, Julien
Publicado: (2019)

Affordability of medicines in the European Union
por: Zaprutko, Tomasz, et al.
Publicado: (2017)

Austerity and Abortion in the European Union
por: Lima, Joana Madureira, et al.
Publicado: (2016)

The political economy of the European Union
por: Dür, Andreas, et al.
Publicado: (2020)

The European Health Union: European Union’s Concern about Health for All. Concepts, Definition, and Scenarios
por: Nabbe, Marie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0rmnt5blvdamt4n8ffi40b9rq1